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During percutaneous coronary intervention (PCI) in patients with acute coronary 
syndrome balloon inflation or stent deployment leads to fragmentation of thrombus 
causing microembolization and myocardial damage 1. Manual thrombus aspiration 
(TA) allows effective retrievement of thrombus in 70% to 80% of patients with ST-
elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction 
(NSTEMI) 2,3. TA use in STEMI patients enhances myocardial perfusion, reduces the 
incidence of microvascular obstruction and improves prognosis 2,4,5. However, data 
on TA in NSTEMI patients are scarce. One small study investigating TA in NSTEMI 
patients who underwent early revascularization demonstrated that TA is associated 
with high retrieval rates of thrombus with a marked reduction in Thrombolysis In 
Myocardial Infarction (TIMI) thrombus score and an increased rate of TIMI-flow grade 
3 3. No data are available on thrombus aspiration in initially conservatively treated 
NSTEMI patients. TA is frequently performed when thrombus is visible on coronary 
angiography (CAG) although it is known that its accuracy in thrombus detection is 
limited. Intravascular imaging with optical coherence tomography (OCT) enables 
superior assessment of thrombus 6. In this pilot study we investigated the efficacy 
of TA involving imaging with OCT in patients presenting with NSTEMI after initial 
conservative therapy.
 Thirty NSTEMI patients who were conservatively treated the first 72 hours and 
had a clinical indication for PCI were prospectively included. Exclusion criteria 
were: electrocardiographic ST-segment elevation, hemodynamic instability, renal 
dysfunction (serum creatinine >2,26 mg/dL), and inability to perform OCT (TIMI flow 
grade 0 or 1, target vessel diameter <2.5 mm). Before PCI, all patients were treated 
with low molecular weight heparin, aspirin, and clopidogrel 7. PCI was performed 
in the following order: first, OCT acquisition was performed (C7 imaging system, 
DragonFly catheter St. Jude/LightLab Imaging); second, TA was performed (6F Export 
Aspiration Catheter, Medtronic), followed by a second OCT acquisition; third, the 
culprit lesion was treated with stenting, followed by a third OCT acquisition. Effective 
TA was defined as the presence of atherothrombotic material in the aspirated samples 
and the material was analyzed as previously described 2.
 Angiographic analysis involved assessment of TIMI flow grade and TIMI thrombus 
score. OCT images were analyzed off-line using dedicated software (QIvus 2.1, Medis 
medical imaging systems). Identical regions of interest (ROI) of the three OCT pullbacks 
were identified using landmarks  of the coronary arteries. Quantitative analyses were 
performed by detection of lumen areas, diameters and volumes of the ROI were 
calculated. Differences in pullback lengths between the patients were compensated 
by calculating a normalized ROI 8: Normalized ROI = [ROI volume/ no. slices in ROI 
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pullback] x median no. slices in ROIs of the population. Thrombus was visually scored 
as a mass protruding into the coronary vessel lumen 6. 
 The study was approved by the Ethics Committee of the University Medical Centre 
Gron ingen and all participants provided written informed consent. 
 Continuous variables are presented as means±standard deviation or as medians 




Male gender 24 (80)





Current smoker 10 (33)
Family history 11 (37)
Previous CABG 1 (3)
Previous myocardial infarction 4 (13)
Previous PCI 4 (13)
Peak Troponin I, μg/L 1.07 (0.20–12.02)
Peak Troponin T, μg/L 0.14 (0.06-0.45)
Time from last complaints to PCI, days 4.4 (3.2–6.0)
Multivessel disease 12 (40)
Anterior infarction 16 (54)
Probability of in-hospital death (GRACE risk score)
Low (<1%) 15 (50)
Intermediate (1-3%) 12 (40)
High (>3%) 3 (10)
Histopathologic analysis
Effective thrombus aspiration 6 (20)
Thrombus
White platelet thrombus 6 (20)
Red erythrocyte rich thrombus 0 (0)
Plaque
Thrombus with plaque component 6 (100)




Small (<0.5 mm) 3 (10)
Medium (0.5 - 2 mm) 3 (10)
Large (>2 mm) 0 (0)
Table 1. Baseline and histopathologic characteristics
The data are mean±SD, median, IQR, or numbers (%). CABG = coronary artery 
bypass graft; IQR = interquartile range; mm = millimeter; SD = standard deviation. 
Casts were defined as fragmental filter casts of loosely cohesive platelets which may 
not be defined as thrombus.
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post-hoc test was used to compare continuous variables. Categorical variables 
are presented as numbers and percentages and were compared using the χ2 test. 
Statistical significance was defined as a two-sided p-value of <0.05. 
 Clinical and histopathological patient characteristics are presented in Table 1. 
Median time after the last complaints to PCI was 4.4 days. Histopathological analysis 
of the aspirated material showed aspiration of thrombus in only 20% of patients, 




Thrombus 18 (60) 19 (63) 0 (0) <0.001
TIMI Thrombus score <0.001
0 12 (40) 11 (37) 30 (100)
1 17 (57) 19 (63) 0 (0)
2 1 (3) 0 (0) 0 (0)
3/4/5 0 (0) 0 (0) 0 (0)
TIMI flow grade 0.014 
0/1 0 (0) 3 (10) 0 (0)
2 15 (50) 11 (37) 6 (20)
3 15 (50) 16 (53) 24 (80)
Optical coherence 
tomography
Thrombus 17/30 (57) 19/30 (63) 19/30 (63) NS
Thrombus color
      White 11/17 (65) 13/19 (68) NA
      Red 6/17 (35) 6/19 (32) NA
ROI length (mm) 24.23±9.27 24.23±9.27 24.23±9.27
ROI volume (mm) 142.90±78.58 140.77±76.17 193.25±87.53†‡ <0.001*
Normalized ROI volume 
(mm3)
134.35±53.65 132.90±55.77 186.10±59.60†‡ <0.001*
Average area (mm2) 5.75±2.33 5.68±2.40 8.02±2.59 †‡ <0.001*
MLA (mm2) 1.69±1.04 1.81±1.12 5.66±2.62 †‡ <0.001*
Average diameter 
(mm)
2.59±0.52 2.56±0.55 3.14±0.53 †‡ <0.001*
Largest diameter (mm) 3.50±0.71 3.43±0.74 3.71±0.64 †‡ <0.001*
MLD (mm) 1.41±0.40 1.46±0.42 2.61±0.62 †‡ <0.001*
Table 2. Angiographic and OCT characteristics
* 3-way comparison (before TA, after TA, after stent)
† p<0.05 vs. before TA
‡ p<0.05 vs. after TA
The data are mean ± SD, or numbers (%). CROI = culprit region of interest; MLA = minimal lumen 
area; MLD = minimal lumen diameter; mm = millimeter; NA = not available; NS = not significant; ROI = 
region of interest; SD = standard deviation; TA = thrombus aspiration; TIMI = thrombus in myocardial 
infarction.
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which were small amounts of fragmented atherosclerotic debris.
 The angiographic and OCT data are provided in Table 2. TIMI thrombus score of 
0 and 1 was observed in 29 patients before TA and in all patients after TA. Similarly, 
TIMI-flow did not improve after TA (TIMI-flow <3 in 15 patients before TA versus 16 
patients after TA). Thrombus on OCT was observed in 17 patients, the majority being 
white thrombus. In 2 patients minimal amounts of white thrombus were induced by 
the guide wire or manipulation with the TA catheter. Moreover, minimal amounts 
of thrombus with plaque protrusion were observed after stent implantation in 19 
patients (mean volume 1.67±1.69 mm3). Mean volumes, diameters and areas of the 
ROIs were not significantly different before and after TA. 
 This study provides novel insight into TA in NSTEMI patients who underwent initial 
conservative therapy. First, although thrombus was observed on OCT in more than 
half of patients, the rate of retrieval of thrombus was low and only small amounts 
of atherothrombotic debris were found by histopathological analysis. Second, TA did 
not result in improved blood flow in the culprit coronary artery or in decrease of 
intracoronary thrombus burden on OCT. Revascularization results in better prognosis 
in NSTEMI patients 7. However, embolization of thrombus into the microvasculature in 
patients with acute coronary syndrome may lead to microvascular obstruction which 
may be of prognostic significance 9,10. Although TA in STEMI patients and less evidently 
in NSTEMI patients with early revascularization resulted in better TIMI flow, in the 
present study though, TIMI flow after TA did not improve. Also, no clear improvement 
of vessel lumen volumes and areas of the vessel were observed on OCT. It is worth 
mentioning though, that with continuous improvements of the device technology an 
increased rate of effective TA may be expected with a new generation TA catheters 
also in NSTEMI patients with less thrombus load.
 Several study limitations should be mentioned. First, the applicable guidelines at 
the start of the study recommended early catheterization only in NSTEMI patients with 
features of high risk, whereas current guidelines recommend PCI within 72 hours in 
all patients 7. Second, this pilot study had a limited sample size and was designed only 
to investigate the principle of TA in patients with expectedly low thrombus burden. 
Finally, the effect of TA was assessed by measuring differences of the intraluminal 
volume between OCT runs since direct quantification of thrombus is limited with OCT.
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